aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $287.90 million. The enterprise value is $224.54 million.

Market Cap	287.90M
Enterprise Value	224.54M

Important Dates

The last earnings date was Wednesday, May 7, 2025, after market close.

Earnings Date	May 7, 2025
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 88.86 million shares outstanding. The number of shares has increased by 33.04% in one year.

Current Share Class	88.86M
Shares Outstanding	88.86M
Shares Change (YoY)	+33.04%
Shares Change (QoQ)	+4.55%
Owned by Insiders (%)	2.27%
Owned by Institutions (%)	58.32%
Float	81.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.84
P/TBV Ratio	3.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.79, with a Debt / Equity ratio of 0.17.

Current Ratio	7.79
Quick Ratio	7.24
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -79.70% and return on invested capital (ROIC) is -45.00%.

Return on Equity (ROE)	-79.70%
Return on Assets (ROA)	-39.82%
Return on Invested Capital (ROIC)	-45.00%
Return on Capital Employed (ROCE)	-77.46%
Revenue Per Employee	n/a
Profits Per Employee	-$975,569
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +91.72% in the last 52 weeks. The beta is 0.79, so aTyr Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+91.72%
50-Day Moving Average	3.28
200-Day Moving Average	2.96
Relative Strength Index (RSI)	48.38
Average Volume (20 Days)	1,051,756

Short Selling Information

The latest short interest is 11.69 million, so 13.16% of the outstanding shares have been sold short.

Short Interest	11.69M
Short Previous Month	10.03M
Short % of Shares Out	13.16%
Short % of Float	14.27%
Short Ratio (days to cover)	7.01

Income Statement

Revenue	n/a
Gross Profit	-54.37M
Operating Income	-67.05M
Pretax Income	-53.93M
Net Income	-63.41M
EBITDA	-66.35M
EBIT	-67.05M
Earnings Per Share (EPS)	-$0.80

Full Income Statement

Balance Sheet

The company has $76.35 million in cash and $12.99 million in debt, giving a net cash position of $63.36 million or $0.71 per share.

Cash & Cash Equivalents	76.35M
Total Debt	12.99M
Net Cash	63.36M
Net Cash Per Share	$0.71
Equity (Book Value)	74.86M
Book Value Per Share	0.84
Working Capital	72.59M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$62.16 million and capital expenditures -$48,000, giving a free cash flow of -$62.21 million.

Operating Cash Flow	-62.16M
Capital Expenditures	-48,000
Free Cash Flow	-62.21M
FCF Per Share	-$0.70

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-33.04%
Shareholder Yield	-33.04%
Earnings Yield	-22.03%
FCF Yield	-21.61%

Analyst Forecast

The average price target for aTyr Pharma is $18.60, which is 474.07% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.60
Price Target Difference	474.07%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	362.79%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	0.0714285:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	2